AMH for predicting poor ovarian responders in GnRH antagonist cycles

Human Reproduction

Volumn 27, Issue 6, 2012, Pages 1876-1877

  Polyzos, Nikolaos P ^a   Tournaye, Herman ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN ANTAGONIST; MUELLERIAN INHIBITING FACTOR;

DIAGNOSTIC ACCURACY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LETTER; OOCYTE; OOCYTE RETRIEVAL; PREDICTIVE VALUE;

EID: 84861533623     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des120     Document Type: Letter

References (3)

1. Andersen AN, Witjes H, Gordon K, Mannaerts B; on behalf of the Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod 2011; Sep 27. [Epub ahead of print] PubMed PMID: 21954280.
2. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. HumReprod 2011;26:1616-1624.
3. Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011;96:1058-1061.e7.